A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility.

A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility.

Aspirin, dipyridamole and clopidogrel are effective in secondary vascular prevention. Combination therapy with three antiplatelet agents might maximise the benefit of antiplatelet treatment in the secondary prevention of ischaemic stroke.A randomised, parallel group, observer-blinded phase II trial...

Full description

Bibliographic Details
Main Authors: Nikola Sprigg, Laura J Gray, Tim England, Mark R Willmot, Lian Zhao, Gillian M Sare, Philip M W Bath
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-08-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2481397?pdf=render

Internet

http://europepmc.org/articles/PMC2481397?pdf=render

Similar Items